KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Biomarin Pharmaceutical (BMRN) over the last 16 years, with Q3 2025 value amounting to -$13.6 million.

  • Biomarin Pharmaceutical's Deferred Taxes fell 21210.98% to -$13.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.5 million, marking a year-over-year increase of 91286.04%. This contributed to the annual value of $56.1 million for FY2024, which is 22471.04% up from last year.
  • Per Biomarin Pharmaceutical's latest filing, its Deferred Taxes stood at -$13.6 million for Q3 2025, which was down 21210.98% from $33.3 million recorded in Q2 2025.
  • In the past 5 years, Biomarin Pharmaceutical's Deferred Taxes registered a high of $42.4 million during Q4 2024, and its lowest value of -$51.3 million during Q4 2022.
  • Its 5-year average for Deferred Taxes is -$445000.0, with a median of -$1.3 million in 2022.
  • As far as peak fluctuations go, Biomarin Pharmaceutical's Deferred Taxes crashed by 133099.22% in 2022, and later surged by 987508.77% in 2025.
  • Quarter analysis of 5 years shows Biomarin Pharmaceutical's Deferred Taxes stood at -$3.6 million in 2021, then tumbled by 1330.99% to -$51.3 million in 2022, then soared by 51.61% to -$24.8 million in 2023, then skyrocketed by 270.61% to $42.4 million in 2024, then crashed by 132.19% to -$13.6 million in 2025.
  • Its Deferred Taxes was -$13.6 million in Q3 2025, compared to $33.3 million in Q2 2025 and $28.4 million in Q1 2025.